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ABSTRACT
Ventilator-associated pneumonia is one of the critical complications identified
by a chest x-ray (CXR). However, there is a controversy about the use of CXRs.
Overuse of the CXR has also identified concern among the ICU patient population.
The purpose of this evidenced-based practice project was to determine if there were
differences in patient outcomes when receiving daily routine CXRs as compared to
clinically-indicated CXRs. Patient outcomes measured were: ICU length of stay,
complications while on the ventilator and ICU mortality, number of ventilator days,
diagnostic efficacy, therapeutic efficacy, costs, and radiation exposure
The author identified 30 articles in the search process. These articles were
reduced to 15 after identifying duplicates and applying the inclusion and exclusion
criteria. Analysis was performed using an evidence table according to the process
developed by Melynk and Fineout-Overholt. Analysis of the research findings from
15 studies that included randomized clinical trials, observational studies, cohort
study, cluster randomized crossover study, meta-analysis, blind-peer reviews, and
expert opinions revealed moderate support for the use of clinically-indicated CXRs
for patients in the ICU on a ventilator. Following the analysis of the literature a retrospective chart audit was performed to determine if practice patterns in my
institution matched the recommendations in the literature.
A sample of 60 patient records was drawn from 234 records of patients who
were admitted to the medical ICU between June 1, 2014 and August 31, 2014.
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The sample was equally divided between men and women who were primarily
Caucasian with a mean age of 59.3. The most common admitting diagnoses were:
ventilator dependent respiratory failure, sepsis, and chronic obstructive pulmonary
disease. Patient outcomes were measured using a researcher developed chart audit tool.
Analysis of the chart audit data revealed that in a three month period only one patient
was treated with the clinically-indicated CXR regimen. The recommendation is that the
professional practice group should begin discussion regarding the development of a
policy and procedure in order to differentiate between patients who need daily routine
versus clinically-indicated CXRs for improved outcomes and adherence to the current
evidence.

v

TABLE OF CONTENTS

ACKNOWLEDGEMENTS .............................................................................................. ii
ABSTRACT...................................................................................................................... iii
LIST OF TABLES ........................................................................................................... vii
LIST OF FIGURES ......................................................................................................... viii
LIST OF ABBREVIATIONS ........................................................................................... ix
CHAPTER I: – INTRODUCTION....................................................................................1
Description of Clinical Problem ...................................................................................2
Scope of Problem ..........................................................................................................5
Analysis of Current Practice Guidelines/ Documented Need for Change ....................7
Discussion of Practice Innovation/Best Practice to Address Problem..........................9
Statement of Problem/Purpose......................................................................................9
Summary ......................................................................................................................12
CHAPTER II: - REVIEW OF THE LITERATURE .......................................................13
Search Process .............................................................................................................13
Analysis of the Evidence .............................................................................................14
ICU Length of Stay ......................................................................................................15
Complications While on the Ventilator & ICU Mortality ...........................................19
Number of Ventilator Days ..........................................................................................21

vi

Diagnostic Efficacy......................................................................................................25
Therapeutic Efficacy ....................................................................................................28
Costs.............................................................................................................................30
Radiation Exposure ......................................................................................................31
Synthesis of Findings ...................................................................................................33
Discussion of Potential Barriers/Supports for Adoption of Practice Innovation .........34
CHAPTER III: - METHODS............................................................................................35
Design ......................................................................................................................35
Participants & Setting ..............................................................................................35
Instruments ...............................................................................................................37
Procedure .................................................................................................................37
Protection of Human Subject Health Information ...................................................38
Data Analysis ...........................................................................................................39
Summary ..................................................................................................................41
CHAPTER IV: - RESULTS ............................................................................................41
Description of Sample..............................................................................................41
Analysis of the Evidence-Based Practice Question .................................................43
Summary ..................................................................................................................44
CHAPTER V: - DISCUSSION .......................................................................................45
Introduction ..............................................................................................................45
Recommendations for Practice ................................................................................45
Recommendations for Policy Development ............................................................46
Recommendations for Research ..............................................................................46
Recommendations for Education .............................................................................47

vii

Summary ...................................................................................................................47
REFERENCES ...................................................................................................................48
APPENDIX A: EVIDENCED TABLE .............................................................................51
APPENDIX B: Hierarchy of Evidence –Rating System ...................................................55
APPENDIX C: CITI Training ...........................................................................................56

viii

LIST OF TABLES
T able 1.1 PICOT Definitions ...........................................................................................10
Table 2.1 Hierarchy of Evidence ......................................................................................15
Table 2.2 Quality Level of the Articles Measuring Length of ICU Stay..........................16
Table 2.3 Quality Level of Articles Measuring Complications While on the Ventilator .19
Table 2.4 Quality Level of the Articles Measuring Number of Ventilator Days .............22
Table 2.5 Quality Level of the Articles Measuring Diagnostic Efficacy .........................26
Table 2.6 Quality Level of the Articles Measuring Therapeutic Efficacy ........................28
Table 2.7 Quality Level of the Costs ................................................................................30
Table 2.8 Quality Level of the Radiation Overexposure ..................................................32
Table 2.9 Final Synthesis of the Literature .......................................................................34
Table 3.1 Data Analysis ....................................................................................................41
Table A.1 Evidence Table.................................................................................................51
Table B.1 Hierarchy of Evidence – Rating System ..........................................................55

ix

LIST OF FIGURES
Figure 1.1 VAP Pathogenesis Factors ...............................................................................4

x

LIST OF ABBREVATIONS
APRN ..................................................................... Advanced Practice Registered Nurse
CDC ........................................................... Center For Disease Control And Prevention
CXR ............................................................................................................ Chest X-Ray
ICU.................................................................................................... Intensive Care Unit
LOS .......................................................................................................... Length of Stay
MV ............................................................................................ Mechanical Ventilation
NHSN.................................................................... National Healthcare Safety Network
OR ................................................................................................................ Odds Ratio
USC.................................................................................. University of South Carolina
RCT........................................................................................ Randomized Clinical Trial
SBT ..................................................................................... Spontaneous Breathing Trial
SD ..................................................................................................... Standard Deviation
WMD .................................................................................... Weighted Mean Difference

xi

CHAPTER 1- INTRODUCTION
Eighty-six percent of nosocomial pneumonias are associated with mechanical
ventilation and are termed ventilator-associated pneumonia (VAP). According to the
Center for Disease Control and Prevention (CDC) (2014) more than 300, 000 patients
receive mechanical ventilation in the United States every year. These patients are at high
risk for complication and poor outcomes, including death (CDC, 2014). Complications
of VAP can lead to longer stays in the Intensive Care Unit (ICU) and hospital, longer
duration of mechanical ventilation, increased risk of disability and death, and increased
healthcare costs (CDC, 2014). Mortality in patients with acute lung injury on mechanical
ventilation has been estimated to range from 24% in persons 15-19 years of age up to
60% for patients 85 years and older (CDC, 2014).
The National Healthcare Safety Network (NHSN) is the nation’s most widely
used healthcare-associated infection (HAI) tracking system (CDC, 2014). CDC (2014)
further reports that NHSN provides facilities, states, regions, and the nation with data
needed to identify problem areas, measure progress of prevention efforts, and ultimately
eliminate HAIs. The Centers for Medicaid and Medicare (CMS) has partnered with the
NHSN in an effort to report and track such a hospital inpatient quality reporting program.
For the year 2010, NHSN facilities reported more than 3,525 VAPs, and the VAP
incidence for various types of hospital units ranged from 0.0-5.8 per 1,000 ventilator days
(CDC, 2014).
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Chest Radiographs (CXR) are a common intervention used in the ICU to
visualize and diagnose VAP. However, there has always been a concern about the
overuse of diagnostic studies such as the CXR for patients who are mechanically
ventilated in the ICU setting secondary to various adverse outcomes including costs
(Oba & Zaza, 2010). There has also been a concern regarding the dose of radiation
that is associated with the overuse of CXRs (Oba & Zaza, 2010). This problem is of
special concern in the ICU because current standard practice is for patients to receive
a CXR routinely on a daily basis (Prat, 2009).
The purpose of this evidenced-based practice project is to compare daily
routine CXR versus clinically-indicated CXR in preventing VAP in adult ICU
patients’ on ventilators. The goal of this project is to determine if daily routine CXRs
produce better patient outcomes than clinically-indicated CXRs. Chapter 1 presents a
description of the problem, scope of the problem, documented need for analysis of
current practice guideline (i.e. documented need for change), discussion of practice
innovation (i.e. best practice to address the problem), statement of the problem/
purpose, and summary.
Description of the Problem
Ventilator-associated pneumonia is defined as an airway infection that
develops more than forty-eight hours after a patient is intubated (Ibrahim, Hill,
Fraser, & Kollef, 2001). Ventilator-associated pneumonia arises when there is
bacterial invasion of the pulmonary parenchyma in a patient receiving mechanical
ventilation (Coffin, et al., 2008).
There are common diagnostic tests such as a CXR that are performed in acute
care settings to help visualize and manage a patient’s pulmonary status.
2

Patients that require intubation and mechanical ventilation in the ICU are especially
in need of diagnostic test such as the CXR. The CXR has allowed intensivist
healthcare providers to directly assess endotracheal tube positioning for adequate
oxygenation and ventilation via the pulmonary system (Siela, 2002). A daily CXR
may also provide a non-invasive internal visualization of the pulmonary tree
including the trachea, right and left lung fields, cardiac silhouette, mediastinum,
diaphragm, pulmonary arteries, bony structures, and line placement (Siela, 2002).
Ventilator-associated pneumonia is one of the critical complications identified
by a CXR. This evidenced-based practice project will focus on identifying
assessment variables and or outcomes that determine clinical significance of daily
routine CXRs, and to also identify the best practices for prevention of VAP with use
of the CXR.
The clinical characteristics that lead to VAP include: inoculation of the
formerly sterile lower respiratory tract (typically arising from aspiration of
secretions), colonization of the aero-digestive tract, or use of contaminated equipment
or prescribed medications (Coffin, et al., 2008). Risk factors for VAP also affect the
incidence of ventilator-associated events (VAE) in the adult medical ICU patient
population. Therefore complications of VAP are termed (VAEs). See Figure 1.1
below which illustrates the pathogenesis factors for VAP:
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Figure 1.1.VAP Pathogenesis Factors. Reproduced with permission from Zolfaghari
and Wyncoll
Critical Care 2011 15:310 doi:10.1186/cc10352,
http://ccforum.com/content/15/5/310/figure/F1?highres=y:
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Coffin et al. (2008) reported risk factors for VAP to include prolonged
intubation, enteral feeding, witnessed aspiration, paralytic agents, underlying illness,
and extremes of age such as the older adult. Other risk factors of concern identified
for VAP risk factors included: overall health status and comorbid health conditions.
Pre-existing conditions that increase the risk for VAP in intubated and mechanically
ventilated patients include smoking and various microbial pathogens including
pseudomonas species and other highly resistant gram-negative bacilli, staphylococci,
enterobacteriaceae, streptococci, and haemophilus species (Park, 2005). Antibioticresistant pathogens such as pseudomonas and acinetobacter species and methicillinresistant strains of staphylococcus aureus are much more common after prior
antibiotic treatment or prolonged hospitalization or mechanical ventilation, and when
other risk factors are present (Park, 2005). The bacterial pathogens responsible for
VAP also vary depending on patient characteristics and in certain clinical
circumstances, such as in acute respiratory distress syndrome (ARDS) or following
tracheotomy, traumatic injuries or burns (Park, 2005).
Another variable contributing to the debate about daily routine versus
clinically-indicated CXRs is radiation overexposure. Radiation overexposure not
only affects the patient but also staff members in the surrounding areas. All may be
inadvertently exposed to dosages of overdoses of radiation (Prat, 2009).
Scope of the Problem
Pneumonia is the second-most-common hospital-acquired infection (HAI) in
the United States accounting for 17.8% of all hospital-acquired infections and 40,000
to 70,000 deaths per year (Iregui & Kollef, 2001). Healthcare-associated pneumonia
(HAP) and VAP are the second-most-common cause of nosocomial infection overall
(Rostein et al., 2008).
5

Also, both HAP and VAP are the most common causes documented in the intensive
care unit (Rotstein et al., 2008).
In the adult ICU patient population, the incidence of VAP for various types of
hospital units ranged from 0.0-5.8 per 1,000 ventilator days (CDC, 2014). Ventilatorassociated pneumonia, sepsis, ARDS, pulmonary embolism, barotrauma, and
pulmonary edema are among the complications that can occur in patients receiving
mechanical ventilation (CDC, 2014). Such complications can lead to longer duration
of mechanical ventilation, longer stays in the ICU and hospital, increased healthcare
costs, and increased risk of disability and death.
In the past 20 years, the overall incidence of HAIs in the United States has
increased by 36% (Stone, 2009). Annually, approximately 2 million patients suffer
from a HAI and an estimated 90,000 of these patients die (Stone, 2009). This statistic
ranks HAI as the fifth leading cause of death in acute care hospitals settings (Stone,
2009). CDC (2014) estimated that more than 300,000 patients receive mechanical
ventilation every year. Given this staggering statistic referencing VAP mortality, the
need for better source control of this clinical phenomenon is critically important.
The Center for Medicaid and Medicare Services (CMS) outlined various
indicators for quality healthcare outcomes for patients’ in acute care facilities. In
addition, and in the interest of promoting high-quality, patient-centered care and
accountability CMS (2013) and the Hospital Quality Alliance (HQA) began publicly
reporting VAP in June 2008. Publicly reporting these measures increases the
transparency of hospital care, provides useful information for consumers choosing
care, and assists hospitals in their quality improvement efforts (CMS, 2013).
Ventilator-acquired pneumonia is such a prevalent and important issue that now CMS
and HQA are tracking and reporting these events for consumers.
6

The direct relationship that affects the consumer (i.e. patient) is that of costs.
Therefore, another important aspect associated with scope of the problem included
identifying the effects of costs associated with ventilated patients with VAP. Factors
influenced by VAP included addressing the costs of the daily CXR versus clinicallyindicated, costs associated with antibiotic therapy, and average costs of ventilated
patients with VAP versus those who do not have VAP.
Analysis of Current Practice Guidelines
Documented Need for Change
Ganapathy et al. (2012) argued that many providers in the intensive care
setting are concerned about the severity of cardiopulmonary illness and complexity of
medical intervention. One of the biggest concerns of providers with the consideration
of transition to clinically-indicated CXR included risk of patient complications and
the risk for mortality in the ICU.
A common mortality indicator scale utilized within the ICU setting is that of the
Acute Physiology and Chronic Health Evaluation (APACHE II) score (Kager et al.,
2010). This scale can be used to predict a patients’ risk for mortality given the
patient’s chronic medical history, admission diagnosis, and current clinical status.
Ganapathy et al. (2012) stated that the frequency of complications such as device
malpositioning, pneumothoraces, and cardiac arrthymias have led to recommended
daily routine CXRs for all patients with acute cardiopulmonary problems or receiving
mechanical ventilation. Ganapathy et al. (2012) outlined the advantage of daily
routine CXR to include prompt detection of complications, and thus, earlier treatment
of clinically unsuspected abnormalities, documentation of disease progression or
response to therapy, and educational value for trainees.
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The use of daily routine versus clinically-indicated CXRs to prevent ventilator
associated events such as VAP in ICU patients prompted further investigation by this
author. Furthermore, CDC (2013) evidence suggested that CXR findings alone do not
accurately identify VAP. CDC (2013) further stated that the subjectivity and variability
inherent in CXR technique, interpretation, and reporting make chest imaging ill-suited
for inclusion in a definition algorithm to be used for the potential purposes of public
reporting, inter-facility comparisons, and pay-for-performance programs.
In contrast, there were various pieces of evidence that supported forgoing the
daily routine CXR approach and focusing on a clinically-indicated CXR.
First, Prat (2009) stated that radiology departments likely have little incentive to
abandon the practice of daily routine CXRs as each radiograph taken generates revenue
for the radiology department and the radiologist interpreting it. Second, there is a
strongly engrained practice culture of the daily CXR in the ICU (Oba and ZaZa, 2010).
Critical care providers are ordering daily CXR as a precaution to assure that potential
complications are not missed. However, an abundance of authors argued that outcomes
are the equitable for patients who receive daily routine CXRs or clinically-indicated
CXRs (Clec “h et al., 2008; Fishman & Primack, 2005; Ganapathy, et al., 2012; Graat,
et al., 2005; Graat, et al., 2006; Gratt et al., 2007; Kager et al., 2010; Krivopal et al.,
2003; Kroner et al.,2008; Hejblum et al., 2009; Hendriksen,2007; Magill, et al., 2013;
Oba & ZaZa, 2010; Prat, 2009; Siela, 2002; and Siegel, 2009).
Discussion of Practice Innovation/ Best Practice to Address the Problem
Intensivist health care providers have remained divided over this best practice
clinical quandary for many years. There is evidence to support utilization of
diagnostic tests to guide the clinician’s interventions and management of intubated
and mechanically ventilated patients.
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This evidenced-based practice project aims to evaluate both daily routine and
clinically-indicated CXR best practice in the prevention of VAP for adult ICU
patients on ventilators.
Statement of the Problem/ Purpose
The purpose of this evidenced-based practice project is to determine if daily
routine CXRs produce better patient outcomes than clinically-indicated CXRs. The
evidence-based practice question is: In the adult ICU patient on the ventilator, is there
a difference between daily routine CXRs and clinically-indicated CXRs on patient
outcomes of ICU length of stay, complications while on the ventilator, ICU mortality,
and number of ventilator days, costs, and radiation exposure? Table 1.1 contains the
definitions of population, intervention, comparison, and outcomes as defined by
Melynk & Fineout-Overholt.
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Table 1.1PICOT Definitions
Population of Interest

Adult ICU Intubated and
Mechanically Ventilated
Patient’s
Daily Routine CXRs

Intervention or Issue
of Interest
Comparison of Interest
Outcome Expected

Clinically-Indicated CXRs
ICU Length of Stay
Complication(s) while on
the Ventilator & ICU
Mortality
Number of Ventilator Days
Diagnostic Efficacy
Therapeutic Efficacy
Costs
Radiation Exposure
Time During Hospitalization
of The Patient

Time for the Intervention
to Achieve the Outcome
Definitions

Comparison of Interest: Clinically-indicated CXR in the intubated and mechanically
ventilated patient.
Diagnostic Efficacy: The number of CXRs with new or progressive major predefined
findings divided by the total number of CXRs obtained.
Intervention or Issue of Interest: Daily routine CXR in the intubated and
mechanically ventilated patient.
ICU: Intensive Care Unit
Outcome Expected: Expected outcomes to be evaluated for adult intubated and
mechanically ventilated patients’ include: ICU length of stay, complications while on
the ventilator & ICU mortality, number of ventilator days, diagnostic efficacy,
therapeutic efficacy, costs, and radiation exposure.
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Outcome Definitions
ICU length of stay: The total number of patient days in the intensive care unit.
Complications while on the ventilator and ICU mortality: Ventilator complications
can lead to longer duration of ICU stay, increased risk of disability and death, tube
dislodgement, and increased healthcare costs.
Number of ventilator days: The total number of days the patient is mechanically
ventilated.
Diagnostic efficacy: Is used as an indicator of the value of the CXR to assist in the
development of a diagnosis by a clinician. Diagnostic efficacy includes the total
number of CXRs with new or progressive predefined findings divided by the total
number of CXRs obtained (Kager et al. (2010).
Therapeutic efficacy: Is any intervention that includes changes in antibiotic therapy,
bronchoscopy, administration or change in diuretic therapy, thoracentesis, and
repositioning of endotracheal tube and lines (Clec ‘h et al (2008).
Costs: The total monetary amount billed for each ICU patient CXR.
Radiation exposure: The total amount of radiation associated with CXR.
Population of Interest: Adult ICU intubated and mechanically ventilated patient > 18
years of age. The gender includes male or female patients’ requiring continuous
ventilation for a specific health problem.
Time for intervention to achieve the outcome: Includes the amount of time the
patient requires for the hospitalization.
Mechanical Ventilation: A form of continuous ventilation for extrinsic oxygenation
as measured by breaths per minute, volume in CC of breath per breath, and percent of
oxygen per breath.
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Summary
The next step in the evidenced-based practice process is the literature search
to obtain the evidence to answer the evidenced-based practice question. The evidence
will be organized using an evidence table. This process is explained in detail in
chapter II. Also, the evidence will be analyzed by the author.
In conclusion, the goal of this evidenced-based practice project is to determine
the best method for preventing VAP in mechanically ventilated patients regarding the
utility of daily routine versus clinically-indicated CXRs in patients on ventilators.
Complications such as ventilator-acquired events (VAE) and subsequent VAP can be
fatal and are of major concern for the adult ICU intubated and mechanically
ventilated patient. This evidenced-based practice projects aim is to compare, contrast
and determine the best practice for use of daily routine versus clinically-indicated
CXRs for preventing VAP in adult ICU patients on ventilators. Chapter II will
provide a review of the literature in an attempt to answer the evidenced-based
practice question.
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CHAPTER II - REVIEW OF THE LITERATURE
The evidenced-based practice project began with the development of a clinical
question using the PICOT format as defined by Melnyk & Fineout-Overholt (2011).
Chapter II presents the search process, evidence table, analysis of the literature, and
synthesis of the evidence. The purpose of this evidenced-based practice project is to
determine if daily routine CXRs produce better patient outcomes than clinicallyindicated CXRs. The evidence-based practice question is: In the adult ICU patient on
the ventilator, is there a difference between daily routine CXRs and clinicallyindicated CXRs on patient outcomes of ICU length of stay, complications while on
the ventilator, ICU mortality, number of ventilator days, costs, and radiation
exposure?
Search Process
The search process began with seven electronic databases appropriate for this
project. The databases were CINAHL, University of South Carolina (USC)
Powersearch, MEDLINE OVID, PUBMED, Web of Science, Cochrane Database,
and National Guidelines Clearinghouse. The search used the concepts from the
PICOT definitions: critical care, daily routine, clinically-indicated, CXR, intensive
care unit, patient outcomes, financial impact, mechanical ventilation, diagnostic
efficacy, therapeutic efficacy, and radiation exposure. The search process used an
expanded version of the PICOT definitions to find the broadest possible literature that
might contain information pertinent to this evidenced-based practice question. These
terms included: intensivist, adverse effect, and patient safety.
13

The author identified a number of selection criteria in order to determine
literature that would answer the evidenced-based practice question. All articles were
in English and within the last 10 years, 2003-2013. Articles were excluded if they
pertained to children or did not meet the PICOT definitions. The next step in the
search process involved a systematic search to identify the best evidence to answer
the evidence-based practice question. The search revealed a combination of thirty
randomized clinical trial articles, observational studies, cohort study, cluster
randomized crossover study, meta-analysis, blind-peer reviews, and expert opinion
articles. Patient outcomes measured were: ICU length of stay, complications while
on the ventilator and ICU mortality, number of ventilator days, diagnostic efficacy,
therapeutic efficacy, costs, and radiation exposure. CINAHL produced the most
relevant articles. The articles were reduced from 30 to 15 by eliminating duplicates
and applying the inclusion and exclusion criteria.
Analysis of the Evidence
The first step in analysis was to organize and analyze the evidence. The
evidence was organized using an evidence table described by Melnyk & FineoutOverholt (Appendix A). The categories on the evidence table were reference, quality
rating, method, threats to validity / reliability, findings, and conclusion. They
proposed a hierarchy of evidence rating system that rated research quality from I-VII
with I being the highest quality of evidence and VII being the poorest quality of
evidence. The articles were placed in the evidence table in descending order of
quality with Level I studies listed first and Level VII studies listed last. Table 2.1
displays the levels and their definitions.
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Table 2.1 Hierarchy of Evidence
Level I

Evidence from a systematic
review or meta-analysis of all
relevant randomized clinical trials
(RCT)
Level II
Evidence obtained from welldesigned (RCT)
Level III
Evidence obtained from welldesigned controlled trials without
randomization
Level IV
Evidence from well-designed
case-control and cohort studies
Level V
Evidence from systematic reviews
of descriptive and qualitative
studies
Level VI
Evidence from single descriptive
or qualitative studies
Level VII
Evidence from the opinion of
authorities and /or reports of
expert committees
Melnyk & Fineout-Overholt (2011). Evidenced-Based Practice in Nursing &
Healthcare. A Guide to Best Practice.
The second step in organizing the articles was to identify specific outcomes measured
in the research studies. The outcomes measured included ICU length of stay,
ventilator complications and ICU mortality, number of ventilator days, diagnostic
efficacy, therapeutic efficacy, costs, and radiation overexposure. The analysis began
by focusing on patient outcomes from studies that compared daily routine to
clinically-indicated CXRs.

15

ICU Length of Stay
Four studies, one level I, one level II, and two levels III, compared daily
routine CXR with clinically-indicated CXR on length of stay in ICU for patients on
mechanical ventilation. All studies found that elimination of daily routine CXRs did
not alter length of stay in the ICU.
Table 2.2 Quality Level of the Articles Measuring ICU Length of Stay
Level

Level

Level

Lev

Leve

I

II

III

el

l

l

l

IV

V

VI

VII

-Oba
ZaZa,
Citatio (2010)
Brief

n

Leve Leve

& -Hejblum et al., - Gratt et
(2009)
al., (2007)
Hendrikse
(2007)

Oba & ZaZa (2010) conducted a meta-analysis which included eight studies with
a total of 7078 identified patients. This study aimed to determine whether abandoning
daily routine CXR versus utilization of clinically-indicated CXR would affect patient
outcomes such as ICU length of stay. This study was rated a level I. Of the 7078 adult
patients, 3429 underwent daily routine CXRs and 3649 had the clinically-indicated
CXRs. The authors concluded that there was no statistically significant difference in ICU
length of stay with the daily routine versus clinically-indicated CXR group. The
weighted mean difference was 0.19 days (95% confidence interval: -0.13, 0.51; p = 0.25).
Ultimately, the researchers found that daily routine CXR could safely be eliminated
without compromising patient care or increasing length of stay in the ICU.
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Hendrikse (2007) conducted a prospective observational study in an adult 10bed mixed medical surgical ICU of a teaching hospital. This study was a rated a level
III. He investigated the effects of eliminating daily routine CXR on ICU length of
stay. The sample population included data on 1780 daily routine CXRs in 559
hospital admissions. The study period lasted 1-year and was divided into two parts.
The first part of the study focused on other outcomes variables. However the
second part of the study focused on ICU length of stay (LOS). The second part of the
study revealed 433 CXRs that were obtained in 274 admissions. Of the 559 hospital
admissions 486 patients were evaluated. The researcher learned that of the 79 (4.4%)
daily routine CXRs versus the 138 (15.2%) of clinically-indicated CXRs only 33
(1.9%) of the daily routine CXRs versus the 162 (17.9%) clinically-indicated CXRs
led to a change in ICU length of stay.
The author defined length of stay (LOS) into three different categories. These
three categories were: short stay (1-2 days), intermediate stay (3-14 days), and long
stay (>14 days). The sample population included 589 patients. According to the
author of the 589 patients 349 (61%) had a 1-2 days ICU stay, 179 (32%) had a 3-14
day stay, and 39 (8%) had a greater than or equal to 15 day stay (p-value = <0.001).
In conclusion, there was found to be no change in the ICU length of stay between
patients who had daily versus clinically-indicated CXRs to prevent VAP.
Hejblum et al. (2009) conducted a cluster-randomized, open-label crossover
study where 21 intensive care units from 18 hospitals in France searched to find out if
the use of a daily routine or clinically-indicated strategy for CXR was more
beneficial. This study was rated level II.
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The studies included 967 patients but of those 118 were excluded because they had
been receiving mechanical ventilation for less than 2 days. Overall, 424 patients had
4607 daily routine CXRs and 425 patients had 3148 clinically-indicated CXRs. The
age range for the daily routine CXR group was 51-74 with a mean age of 61, and the
clinically-indicated CXR group ages ranged from 49-74 with a mean of age 63.
The reasons for mechanical ventilation for both sample groups included thoracic
diseases such as: acute respiratory distress syndrome (ARDS) or acute lung injury
(ALI), pneumonia, acute on chronic respiratory insufficiency, cardiogenic edema,
asthma, coma, shock, and postoperative care.
The results of the study supported clinically-indicated CXRs versus daily routine
were safe and did not reduce patient quality of care. The study also demonstrated that
there were no statistically significant differences between patient lengths of stay to
improve with clinically-indicated (13.21%) versus daily routine (13.96%) CXRs for
mechanically ventilated patients (p < 0.28).
Gratt et al. (2007) performed a 5-month prospective, nonrandomized,
controlled study with patients in a 28-bed ICU. The study was divided into two
phases. This study was rated a level III. A total of 3894 CXRs were obtained from
754 patients in phase one which included 2457 daily routine CXRs and 1437
clinically-indicated CXRs (Gratt, 2007). A total of 1267 CXRs were obtained from
622 patients in phase two. The study involved 2,457 participants who received daily
routine CXR and 1,437 participants who received clinically-indicated CXR (Gratt,
2007). In phase 1, patient outcomes were measured for 5 months before the CXR
intervention was implemented.
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Phase 2 began one month after phase 1 concluded. In phase 2, participants received
either daily routine CXRs or clinically-indicated CXRs as determined by their
healthcare providers over 5 months.
The researchers found that not only did the number of CXRs per patient per day
decline from 1.1 days +/-0.3days to 0.6 days+/-0.4 days (p<0.05), but also there was
no statistically significant difference in the phase one versus phase two participants
on length of stay in ICU. Overall, daily routine CXRs did not reduce length of ICU
stay as an effective patient management in the prevention of VAP.
Complication While on the Ventilator and ICU Mortality
Three studies, two level I and one level III, compared daily routine CXR with
clinically-indicated CXR on complications and ICU mortality for patients on
mechanical ventilation. All studies found that elimination of daily routine CXRs did
not change complication rate or ICU mortality.
Table 2.3 Quality Level of the Articles Measuring Complications While on the
Ventilator and ICU Mortality
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Ganapathy, Adhikari, Spiegelman, and Scales (2012) presented a meta-analysis
on the necessity of routine CXR in the intensive care unit. This study was
categorized at the highest rating of I. The purpose of this meta-analysis was to review
the utility of one of the most frequent radiological diagnostic tests performed in the
intensive care setting. The meta-analysis determined potential patient risks and
complications for mechanically ventilated patients.
Ganapathy et al. (2012) argued that many providers in the intensive care setting are
concerned about the severity of cardiopulmonary illness and complexity of medical
intervention. One of the biggest concerns of providers included mechanically
ventilated patient complications and the risk for mortality in the ICU.
Ganapathy et al. (2012) stated that the frequency of complications such as
device malpositioning, pneumothoraces, and cardiac arrthymias have led to
recommended daily routine CXRs for all patients with acute cardiopulmonary
problems or receiving mechanical ventilation. Ganapathy et al., (2012) outlined the
advantage of daily routine CXR to include prompt detection of complications and
thus earlier treatment of clinically unsuspected abnormalities, documentation of
disease progression or response to therapy, and educational value for trainees.
In this meta-analysis, nine studies were included for a total of 39,358 CXRs
conducted on 9,611 patients from the United States, Canada, France, The Netherlands
and Germany (Ganapathy et al., 2012). Pooled data showed that the primary
outcome of ICU mortality did not demonstrate a statistical significance between
clinically-indicated and daily routine CXR groups on ventilator complications and
ICU mortality (95% CI 0.84 to1.28), (p value = 0.72).
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Results were also similar between groups for hospital mortality (95% CI 0.68 to
1.41), (p value = 0.91). Ganapathy et al. (2012) concluded that the meta-analysis did
not detect any statistically significant differences in mortality between daily routine
CXRs and clinically-indicated CXRs.
Oba & ZaZa (2010) conducted a meta-analysis which included eight studies
with a total of 7078 patients. This study aimed to determine whether abandoning
daily routine CXR versus utilization of clinically-indicated CXR would affect patient
outcomes such as ICU mortality. This study was rated a level I. Of the 7078 patients
3429 underwent daily routine CXRs and 3649 had the clinically-indicated CXRs.
The study found that there was no statistically significant difference in ICU mortality
in the daily routine versus clinically-indicated CXR group pooled analysis of 0.92
odds ratio (OR) with a 95% (confidence interval: 0.76, 1.11; (p =0.4) for this
outcome. The study found that elimination of daily routine CXR did not affect ICU
mortality.
Kager, et al. (2010) conducted a prospective nonrandomized controlled study
regarding the value of routinely obtained radiographs for a medical-surgical ICU.
The study was rated a level III. The study took place over a 10 month period in a 28bed mixed medical-surgical ICU. The sample population included a total of 1081
patients of which 854 were daily routine and 227 were clinically-indicated. The study
found that complications such as loss of orotracheal tubes or indwelling catheters may
cause hemodynamic deterioration and in fact may induce more pain and anxiety of
critically-ill patients (Kager et al., 2010).
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Number of Ventilator Days
There were three level II and one level III study that compared routine daily CXR
and clinically-indicated CXR on days of mechanical ventilator. In patients on
ventilators, both of these studies had no statistically significant difference between
groups on days of mechanical ventilation. One level III study drew the same
conclusion. The researcher cautioned that the sample was too small to conclude
anything.
However, the finding is consistent with the two level II studies. All studies found that
elimination of daily routine CXRs did not change number of ventilator days.
Table 2.4 Quality Level of the Articles Measuring Number of Ventilator Days
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Clec’ h, et al. (2008) conducted a level II randomized controlled trial comparing
daily routine CXR with clinically-indicated CXR on days of mechanical ventilation.
The randomized study population included 165 patients who were mechanically
ventilated for 48 hours or more. The sample included 372 patients. 191 patients were
deemed eligible and the remaining 26 were excluded because of: length of mechanical
ventilator days less than 48 hours, reintubation, therapeutic limitation and tracheostomy
(Clec’h, et al. 2008).
After meeting the selection criteria 165 patients were selected to participate in the
study. Eighty-four patients were assigned to the daily routine CXR group and 81 were
assigned to the clinically-indicated CXR group. The number of days of mechanical
ventilation of those receiving daily routine CXRs was approximately 9.7 days versus 9.8
days for those patients in the clinically-indicated CXR group.
Clec ‘h et al. (2008) found no statistically significant difference in the number of
ventilator days when comparing daily routine versus clinically-indicated CXR (p = 0.94).
The author recommended that a rational use of CXRs be based on clinical judgment and
evaluation by the clinical provider.
Krivopal et al. (2003) performed a level II randomized observational study
comparing daily routine CXR and clinically-indicated CXR on length of mechanical
ventilation. There were 94 participants who were hospitalized in medical ICU. 94
patients were evaluated over a 10-month period. A total of 293 CXRs were obtained
from 43 patients in the routine arm of the study (Krivopal et al. (2003). These included
200 daily routine CXRs and 93 clinically-indicated CXRs.
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In the non-routine arm of the study there were 226 CXRs acquired from 51 patients
(Krivopal et al. (2003). The mean age for the routine arm was 64.3 years and nonroutine arm 61.5 years of age (Krivopal et al. (2003). Major co-morbidities for the
routine arm group included: cardiac (35), pulmonary (13), renal (7), endocrine (14),
and neurologic (11) (Krivopal et al. (2003). Major co-morbidities for the non-routine
arm included: cardiac (35), pulmonary (15), renal (9), endocrine (13), and neurologic
(11) (Krivopal et al. (2003). The mean time on the ventilator for the daily routine
CXR group was 7.93 days +/-5.64 days in comparison to 6.76 days +/-4.03 days of
the clinically-indicated CXR group. The difference was not statistically significant (p
=0.2606). The researchers concluded that it would be more prudent to use clinicallyindicated CXRs as this approach was equitable in outcomes on number of ventilator
days (Krivopal et al., 2003).
Hejblum et al. (2009) conducted a cluster-randomized, open-label crossover
study where 21 intensive care units from 18 hospitals in France searched to find out if
the use of a daily routine or clinically-indicated strategy for CXRs was more
beneficial. The study was rated a level II. The study included 967 patients but of
those 118 was excluded because they had been receiving mechanical ventilation for
less than 2 days. Overall, 424 patients had 4607 daily routine CXRs and 425 patients
had 3148 clinically-indicated CXRs. The age range for the daily routine CXR group
was ages 51-74 with a mean of 61, and the clinically-indicated CXR group ages
ranged from 49-74 with a mean of 63. The reasons for mechanical ventilation for
both sample groups included thoracic diseases such as: acute respiratory distress
syndrome (ARDS) or acute lung injury (ALI), pneumonia, acute on chronic
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respiratory insufficiency, cardiogenic edema, asthma, coma, shock, and postoperative
care. The study demonstrated that patients with clinically-indicated CXRs in the ICU
versus daily routine CXRs were found to have fewer days of mechanical ventilation
(p value = 0.009).
In addition, Graat et al. (2006) performed a prospective observational study in a
28-bed, mixed medical-surgical ICU of a university hospital. This study was rated a
level III. The purpose of the study was to determine if daily routine CXRs could be
replaced with clinically-indicated CXR. The study period was over 5 month duration,
and 2,457 daily routine CXRs were completed in754 consecutive ICU patients.
Demographic data for the 754 patients included an average age of 59.8 years, and the
reason for admission to the ICU included: large atelectasis (>2 lobes), large
infiltrates (>1 lobe), severe pulmonary congestion, severe pleural effusion,
pneumothorax/pneumomediastinum, and malposition of the orotracheal tube.
The researchers found that days of mechanical ventilation was not influenced by the
elimination of daily routine CXRs. The data revealed that of 754 patients a total of
3,894 CXRs were completed.
Of these 3,894 CXRs 2,457 were categorized as daily routine (63.1%) and the
remaining as clinically-indicated (Gratt et al. (2006). Gratt et al. (2006) went on to
show that the sensitivity and specificity of the clinicians in predicting changes on
daily routine CXR wer 2.1% (3/145) and 99.3% (2296/2312) respectively. In
addition, Gratt et al. (2006) stated that “although sensitivity improved with those
CXRs that were categorized as clinically-indicated CXRs (21% [8/38]), specificity
dropped to 59% (167/283). However, the study population was small and; therefore,
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the researchers expressed caution about drawing any conclusions. Gratt et al. (2006)
stated that there is a need for not only additional studies, but also additional studies
with a different case-mix before results can be generalized to all types of ICU settings
and ICU patients.
Diagnostic Efficacy
Two studies, one level II and one level III, compared daily routine CXR with
clinically-indicated CXR on diagnostic efficacy for patients on mechanical ventilation.
One of these studies was randomized which increased confidence in the findings. Both
studies found that elimination of daily routine CXRs did not change diagnostic efficacy.
The researcher cautioned that the samples were too small to conclude anything.
Table 2.5 Quality Level of the Articles Measuring Diagnostic Efficacy
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Clec’ h et al. (2008) also conducted a randomized control trial to determine if
daily routine CXRs are useful in mechanically ventilated patients.
191 patients were deemed eligible and the remaining 26 were excluded because of:
length of mechanical ventilator days less than 48 hours, reintubation, therapeutic
limitation and tracheostomy (Clec’h, et al. 2008. After meeting the selection criteria
165 patients were selected to participate in the study. Eighty-four patients were
assigned to the daily routine CXR group and 81 were assigned to the clinically-
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indicated CXR group. As stated in a previous outcome, this study was categorized as
a rating of level II. Clec’h et al. (2008) aimed to compare the diagnostic efficacy of a
clinically-indicated CXR with that of a daily routine CXR. The diagnostic findings of
the daily routine group revealed that most daily CXRs were not helpful with
diagnostic efficacy. Of 885 CXRs obtained, only 64 revealed new findings. New
diagnostic findings on daily routine CXRs accounted for 66% versus clinicallyindicated CXRs 7.2% (p <.0001). In conclusion, the researcher found that clinicallyindicated CXRs in mechanically ventilated patients were associated with better
diagnostic efficacy without impairing patient outcomes.
Kager et al. (2010) conducted a prospective nonrandomized study. This study
was categorized as a level III. The study included patients from a 28-bed mixed
medical-surgical university-affiliated ICU setting.
The demographics of the sample population included an average of 62 (Kager er al.
(2010). Further demographics of the patient population included medical patients
(including cardiology and pulmonary disease patients), surgery patients (including
trauma patients), orthopedic surgery and urology patients), cardiothoracic surgery
patients, and neurology patients (including patients after neurosurgery) (Kager et al
(2010). Throughout the study, diagnostic efficacy of daily routine versus clinicallyindicated use of CXRs was assessed.
Diagnostic efficacy included the number of CXRs with new or progressive
major predefined findings divided by the total number of CXRs obtained. Diagnostic
efficacy was also used as an indicator of the value of the CXR to assist in
development of a diagnosis either by the intensivist clinician or the radiologist.
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Examples of diagnostic efficacy documented in the study included: large atelectasis,
large infiltrates severe pulmonary congestion, massive pleural effusion,
pneumothorax or pneumo-mediastinum or malposition of invasive devices (Kager et
al., 2010).
The findings revealed that during the 10-month period, 5067 CXRs were
obtained in 1330 patients. Of these CXRs, 1081 were admission CXRs within 6 hours
of admission to the ICU. Major abnormalities were defined as: large atelectasis, large
infiltrates severe pulmonary congestion, massive pleural effusion, pneumothorax or
pneumo-mediastinum, and malposition of invasive devices. Kager et al, (2010)
showed that the majority of routinely obtained CXRs did not reveal any new
predefined major abnormalities. Kager et al. (2010) defined major abnormalities as
large atelectasis (>2 lobes) 5 (0.6%), large infiltrate (>1 lobe) 10 (1.2%), severe
pulmonary edema 18(2.1%), massive pleural effusion 11 (1.3%), pneumothorax or
pneumomediastinum 11 (1.3%), or malposition of invasive device 70 (8.2%). Of 854
routine CXRs, 14% or 117 CXRs demonstrated a major abnormality.

This

researcher went on to illustrate that the incidence of potentially clinically relevant
abnormalities on routinely obtained admission CXRs was low.
Therapeutic Efficacy
Two studies, one level II and one level III, compared daily routine CXR with
clinically-indicated CXR on therapeutic efficacy for patients on mechanical
ventilation. All studies found that elimination of daily routine CXRs did not change
therapeutic efficacy in the ICU. One of these studies was randomized.
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Table 2.6 Quality Level of the Articles Measuring Therapeutic Efficacy
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Clec ‘h et al. (2008) also presented data on the therapeutic efficacy of daily routine
CXRs versus clinically-indicated CXRs. This study was rated at level II. 191
patients were deemed eligible and the remaining 26 were excluded because of: length
of mechanical ventilator days less than 48 hours, reintubation, therapeutic limitation
and tracheostomy (Clec’h, et al. 2008). According to Clec’h, et al. (2008) there was
no statistical difference with regard to age, gender, severity source, and reason for
intubation.

After meeting the selection criteria 165 patients were selected to

participate in the study. Eighty-four patients were assigned to the daily routine CXR
group and 81 were assigned to the clinically-indicated CXR group.
Clec’h et al. (2008) aimed to compare the diagnostic efficacy of a clinically-indicated
CXR with that of a daily routine CXR.
According to the study by Clec ‘h et al. (2008) of the 94 clinically-indicated
CXRs, 53 revealed new findings important enough to prompt therapeutic
intervention. Therapeutic intervention included changes in the following: antibiotic
therapy, bronchoscopy, administration or change in diuretics/ dobutamine,
thoracentesis, and repositioning of endotracheal tube and lines. Of the 885 CXRs
obtained in the daily routine group, only 49 revealed a new finding important enough
to prompt therapeutic intervention. Therapeutic intervention statistical data for the
daily routine CXR group included: antibiotic therapy (34), bronchoscopy (9),
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administration or change in diuretics/ dobutamine (5), and thoracentesis (5). Clec’h et
al. (2008). Statistical data for the clinically-indicated group included a total of 94
studies with 53 new findings which include: antibiotic therapy (29), bronchoscopy
(11), administration or change in diuretics/ dobutamine (5), and thoracentesis (4).
Kager et al. (2010) conducted a prospective nonrandomized study. This study
was categorized at a rating of III. Demographics of the sample include a total of 854
patients. The average age was 62 years of age, and most patients had medical,
general surgery, cardiothoracic surgery, or neurosurgery as an admitting diagnosis
Kager et al. (2010). Study findings indicated that approximately one-third of
routinely obtained admission CXRs with a new predefined major abnormality
revealed clinically relevant information (i.e. atelectasis, infiltrate, pneumonia, pleural
effusion, pneumothorax/ pneumomediastinum, or malpositioning of tubes or lines)
Kager et al. (2010). Of the 40 CXRs, 4% of all admission CXRs, 5% of all routinely
obtained CXRs, and 34% of routinely obtained chest x-rays with a predefined major
abnormality resulted in a change in therapy. Kager et al. (2010) found that
therapeutic efficacy resulted in a change in therapy very minimally out of the 854
daily routine CXRs. Incidence of change in therapeutic efficacy is due to: large
atelectasis 1(0.1%), large infiltrate 6 (0.5%), severe pulmonary congestion 2 (0.2%),
massive pleural effusion 4 (0.5%), pneumonthorax/ pneumomediastinum 5 (0.6%),
malposition of invasive devices 30 (3.5%), and total number of CXRs with new
abnormalities 40 (4.7%) Kager t al. (2010). While 40% is high, the research doesn’t
determine if those patients would have been diagnosed with a clinically-indicated
CXR.
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Costs
Two studies, one level I and one level III, compared daily routine CXR with
clinically-indicated CXR on costs of ICU patients on mechanical ventilation. All
studies found that elimination of daily routine CXRs did decrease costs in the ICU.
Table 2.7 Quality Level of the Articles Measuring Costs
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Oba & ZaZa (2010) highly debated use of daily routine versus clinically-indicated
CXRs. The study by Oba & ZaZa was rated a level I because of its high quality rating.
A total of 7078 ICU patients were included in the analysis. Of the 7078, patients 3429
underwent daily routine CXRs and 3649 had the clinically-indicated CXRs. Factors
affecting costs included: length of days on mechanical ventilation, length of stay in the
ICU, length of stay in the hospital, and risks of potential complications. The
researchers concluded that an alternative strategy such as obtaining a CXR only when
clinically-indicated would save healthcare costs (Oba & ZaZa, 2010). According to the
Institute for Healthcare Improvement (2014), VAP as an estimated costs of $40,000 to a
typical hospital stay.
Hendriske (2007) conducted a prospective observational study in an adult 10-bed
mixed medical surgical ICU. This study was rated a level III. This study collected
1780 daily routine CXRs. The sample population included data on 1780 daily routine
CXRs in 559 hospital admissions. The study period lasted 1-year and was divided into
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two parts.

The first part of the study focused on outcome variables such as costs.

However the second part of the study focused on other outcome variables. A total CXR
volume reduction of 35% which equaled $9,900 per bed per year was documented by
the author of this study, however the total number of beds was not revealed.
Conversely, they found a 50% decrease in the total number of CXRs per patient per
day. In the study, a change of practice to clinically-indicated CXRs resulted in a
savings of $100,000/year.
Radiation Exposure
Three studies, one level I, one level three, and one level IV, compared daily
routine CXR with clinically-indicated CXR on radiation overexposure for patients on
mechanical ventilation. All studies found that elimination of daily routine CXRs did
change radiation overexposure in the ICU.
Table 2.8 Quality Level of the Articles Measuring Radiation Overexposure
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In the meta-analysis by Oba and ZaZa (2010), the researchers sought to
examine whether abandoning daily routine CXRs would adversely affect patient
outcomes for missing VAP. Oba and Zaza (2010) examined a total of eight studies
with a total of 7078 identified patients. The mean age for the patients was 62.8 years
(62.5 for routine CXR group and 63.0 for the clinically-indicated group. The author
goes on to say that 95 % of the patients selected were medial (i.e. nonsurgical) and
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61% of these patients were mechanically ventilated. The authors did not include
specific costs analysis information associated with daily routine versus clinically
indicated CXRs. In turn, the researchers found that elimination of daily routine
CXRs did not adversely affect outcomes and in terms for missing VAP but did show
a decrease in radiation exposure Oba and ZaZa (2010) went on to say that there
should be protocols in place to promote clinically-indicated rather than daily routine
CXRs to reduce unnecessary radiation exposures for patients and staff.
Hendriske (2007) found a 50% decrease in the total number of CXRs per patient
per day. Prat (2009) submitted data on radiation exposure in a retrospective
comparative study. The author went on to say that although radiation exposure was
decreased with clinically-indicated CXRs versus daily routine x-rays that the problem
is likely multi-factorial.
Synthesis of Findings
Of the 15 articles reported for this evidenced-based practice project, none of
the studies found a decrease in quality of patient outcomes when using clinicallyindicated CXRs versus daily routine CXRs for adult ICU patients on ventilators.
The quality of the evidence is moderate and the most compelling findings show that
instituting clinically-indicated CXR strategy would not produce adverse patient
outcomes.
In other words using clinically-indicated CXRs would not increase patient risk
for complication as measured by length of stay, number of ventilator days,
complications and mortality. However, diagnostic efficacy and therapeutic efficacy
are not as strongly supported in the literature. More research needs to be done on the
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formula in accurately representing diagnostic and therapeutic efficacy, and there
needs to be validation to measure diagnostic and therapeutic efficacy. Obviously,
cost would be reduced if the number of CXRs were reduced.
Table 2.9 Final Synthesis of the Literature
Outcomes
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Discussion of Potential Barriers/ Supports for
Adoption of Practice Innovation/ Best Practice
Upon review of the literature the author of this evidenced-based practice project
has identified potential barriers and or supports for adoption of practice innovation for
best practice. A readiness assessment was not completed but the barriers identified
here included the author’s foresight of various healthcare disciplines within the acute
care setting.
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These barriers for adoption of practice innovation included provider resistance to
change as a daily CXR is routine and engrained into their current practice. Another
barrier is staffing. Various healthcare disciplines including both nursing and
respiratory therapies assumption that although a daily CXR is not ordered by the
clinician the staff is also resistant to change and will order the CXR as they assume that
provider would have wanted the diagnostic test. Although there is evidence to change
to clinically-indicated CXRs intensivist providers may still be resistant to change
current practice.
Support for adoption of practice innovation for best practice includes the effect on
patient safety as unnecessary test are not performed for those who may not need it,
and also the cost effectiveness for not obtaining an unnecessary diagnostic test.
Changing practice protocol to clinically-indicated CXRs seems promising. Before
making this recommendation to ICU staff, the author will do a chart audit of patients
in an ICU to determine if those outcomes are supported by the evidence. Outcomes
include: ICU length of stay, complications while on the ventilator and ICU mortality,
number of ventilator days, diagnostic efficacy, therapeutic efficacy, costs, and
radiation exposure. Chapter III contains the description of the chart audit and the data
collection process.
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CHAPTER III - METHODS
In order to gather more evidence, the author conducted a chart audit of
mechanically ventilated patients in ICU practice population to determine if there were
any differences in the outcome variables when comparing daily routine to clinicallyindicated CXRs. The author also aimed to determine if these differences in the
outcome variables affected the prevention of VAP. These outcomes include: ICU
length of stay, complications while on the ventilator and ICU mortality, number of
ventilator days, diagnostic efficacy, therapeutic efficacy, costs, and radiation
exposure.
Design
A descriptive study was used to collect and, improve data outcomes. The
population includes medical and cardiovascular ICU patients from a level III trauma
facility. More specifically, the descriptive study was done in the form of a
retrospective chart audit. Pending IRB approval from the organization and the
university the chart audit will commence September 1, 2014, with retrospective chart
review.
Participants and Setting
Medical records of patients with respiratory pathology on ventilators in the ICU
will be reviewed. Charts were reviewed for 30 patients with daily routine CXRs and
30 patients who have had clinically-indicated CXRs for a total of 60 patients at a
North Carolina medical center.
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Patients with respiratory pathophysiology criteria inclusion are selected in order to
compare patients with similar diagnosis. These patients are also the ones most likely
to have ventilator complications such as VAP.
Instruments
The author developed a chart audit tool based on the outcomes identified in the
analysis of research findings in Chapter II. The chart audit tool is divided into eleven
sections. Section one focuses on subject demographic information. Demographic
information includes subject numbers, gender, age, and race. No identifiers will be
linked to the patient’s name or chart number, or medical record. The second section
focused on the subject date of admission, and whether or not the patient was intubated
on admission. The third section identified the respiratory pathology for the
participant on admission. The fourth section reviewed ICU length of stay. Fifth, the
audit tool focused on complications and mortality while on the ventilator in ICU.
Sixth, the number of ICU ventilator days was documented. Seventh, diagnostic
efficacy was reviewed. Eighth, therapeutic efficacy was obtained. Ninth, cost
associated with the number of CXRs was identified. Tenth, the opportunity for
radiation overexposure was identified. The final section includes the type of strategy
used for the CXR, either daily routine or clinically-indicated.
Procedure
The author collaborated with the Informatics Manager and Informatics Analyst
at the institution to identify electronic patient records that met the requirements of the
chart audit. After the selected electronic charts were provided from the Informatics
Analyst, the author initiated and completed the data collection process.
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The author obtained Institutional Review Board (IRB) approval from USC and
the regional medical center to conduct the electronic chart review.
The author also worked with the Informatics Manager at her facility to generate a list
of patients in the medical ICU that fit the inclusion sample criteria.
The data collected was placed on a secure and encrypted flash drive that was
password protected. The password was only known by the author. Next, the author
requested a total of 40 charts per day to review during each 8 hour chart audit day.
No protected health information was removed from or transferred from the
organizations electronic records. The author selected one chart at a time to review
and data was extracted to complete according to the audit tool criteria. Next, the
information was tracked electronically via the same secure and encrypted flash drive.
The data collected was then placed into an excel spreadsheet created by the author.
The excel spreadsheet was also maintained only by the author via a secure and
encrypted flash drive. The chart audit began with ICU patients starting June 1, 2014
and ending August 31, 2014. No patient identifiers were collected except race, age,
and gender.
The author collected, extracted, and trended data via the excel spreadsheet. The
author continued to retrospectively collect data until there are 30 patients with daily
routine CXRs and 30 patients with clinically-indicated CXRs for a total of 60 patients
with similar pathophysiology.
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Protection of Human Subject Health Information
IRB approval was obtained from USC and CaroMont Regional Medical Center. This
project is a quality improvement evidenced-based practice project and; therefore,
organization IRB approval was expedited. Confidential patient health information
was protected by collecting data electronically using a secure flash drive and auditing
each chart individually and closing out charts immediately after data was collected.
There were no patient identifiers on the chart audit tool. Patient names or
identification numbers were never associated with data to the patients’ electronic
medical record. USC IRB committee approval was also expedited as this is
retrospective chart audit evidenced-based practice project.
To ensure human subject protection, the CITI Certification (an ethical training
program facilitator) was completed by the author (See Appendix C). As previously
stated this evidenced-based practice project will be a retrospective chart audit method
design. With use of this methodology therefore there was minimal to no harm to
project participants.
Prior to undergoing the project, an approval to initiate the project was sought
from the Institutional Review Board (IRB) at University of South Carolina.
Furthermore, an approved IRB board was utilized prior to undergoing the project
within the approved acute care facility at CaroMont Regional Medical Center. The
IRB board reviewed the application and made a determination regarding the
application. A compliance officer in the office of sponsored programs emailed to the
author the approval and exempt status and gave permission to proceed with the
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quality improvement project. A copy of the CITI training can be found in Appendix
C.
Data Analysis
After a total of 60 patients are audited that met the authors criteria for this
evidenced based-practice project the data were analyzed via a statistical analysis
system (SAS 9.4). The author took the chart audit tool and created an Excel
spreadsheet that included the demographic information, outcome, and CXR variables.
The demographic variables were analyzed using measures of central tendency.
Descriptive statistics were calculated on the selected variables. Frequency
distribution was used to describe for categorical variables. Continuous variables
statistics included measure of central tendency (mean and median) and measure of
spread (standard deviation and range). The descriptive statistics for main variables
were conducted by group.
Simple inferential statistics were used to analyze the differences between
groups by outcomes. The statistical procedures were based on the level of data.
Table 3.0 displays the outcome variable, measurement from the chart audit, and
statistical procedure.
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Table 3.1 Data Analysis
Variable

Measurement From Chart
Audit

Statistical Procedure

Length of Stay

Number of Days

1-way Anova (comparing 2
groups)

ICU Complication

Number of Complication

1-way Anova

ICU Mortality

Mortality: Yes/No

CHI Square Analysis

Number of Days of

Number of Days

1-way Anova

Number of Complication

Two-Sample Proportion

Divided By Number of

Test

Ventilation
Diagnostic Efficacy

Days in ICU
Therapeutic Efficacy

Number of Interventions

1-way Anova

Cost

Cost Facility Charges Per

1-way Anova

CXR
Radiation

Number of CXRs

1-way Anova

Summary
The evidenced based-practice project question was answered using a descriptive
study with a chart audit tool. IRB approval from the data collection site and the
academic institution were both obtained. Chapter 4 of this evidenced-based practice
project will describe the findings of data collection.
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CHAPTER IV - RESULTS
INTRODUCTION
The purpose of this project was to determine if there were any differences in
patient outcomes with ICU patients on ventilators in the prevention of VAP between
those who received daily routine CXRs and those who received clinically-indicated
CXRs. The patient outcomes measured were ICU length of stay, complications while
on the ventilator, ICU mortality, number of ventilator days, costs, and radiation
exposure? Chapter 2 indicated that there were no differences in patient outcomes
with VAP but there was significant financial costs savings with clinically-indicated
CXRs. A retrospective chart audit of patients in the authors’ practice site was
conducted to see if those patient outcomes matched the literature findings. Chapter
IV provides an analysis of the results from the evidenced-based practice project.
Chapter IV is divided into the following sections: description of the sample, analysis
of the evidenced-based practice question, additional analysis, and summary.
Description of Sample
The population of records from which the sample was drawn was generated by a
regional hospitals informatics analyst. The hospital analyst, using the chart audit tool
as a guide, generated a list of 234 patients admitted to the medical ICU from April 1,
2014 to September 1, 2014. The author began by examining the electronic charts in
sequence and selected every chart that met the inclusion criteria.
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The sample consisted of 60 records of patients who had been admitted and discharged
from an 8-bed medical ICU in a North Carolina regional hospital. All of the patients
were on ventilators. The sample was evenly divided between male (30) and females
(30). The mean age the sample was 59.3 with a SD (Standard Deviation) of 16.6. The
ethnicity in the sample consisted of 54 Caucasian, 5 African American, and 1 other.
The most common reasons for admission to the ICU were: ventilator
dependent respiratory failure, sepsis, and chronic obstruction pulmonary disease
exacerbation. The mean number of days in the ICU was 4.5with a SD of 0.8. The
mean number of days on the ventilator in the ICU was 4.7 with a SD of 1.6. Data
were collected from records of patients hospitalized between June 1, 2014 and August
31, 2014. There were a total of 10 ICU deaths for patients on the ventilator for the
duration of this data collection timeframe. The remaining 50 patients transferred
either to the post-intensive care unit, another monitored bed unit, or the medical floor.
Analysis of the Evidenced-Based Practice Question
Following the review of the 60 records the author discovered that CXRs for
only one patient used the clinically-indicated method. The authors choose to stop
data collection because it was clear that the current practice is for all ventilated
patients to receive a daily CXR. If only one patient per every three months is ordered
to get clinically-indicated CXRs the author would have to go back 20 months or
almost two years to have any chance of accruing a clinically-indicated CXR group.
The danger in this approach is that the patients would not be homogenous. Policy
changes, practice changes, equipment changes, personnel changes, and disease
prevalence patterns would make the threat of history inevitable. While the failure to
accrue a clinically-indicated CXR group is disappointing the findings are
illuminating.
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The current accepted practice in the medical ICU does not conform to findings
in the literature. This practice pattern is understandable because the following: fear of
missing a potential patient complication, fear of a malpractice suit, profit benefit, cost
of doing multiple CXRs, tradition, and clinician comfort levels. The challenge for
medical ICU providers is to find a balance between excessive costs, radiation
overexposure, and patient safety versus provider comfort.
Summary
In the critical care setting the need for diagnostic imaging plays a crucial role in
the assessment, and appropriate management of the ICU patient on a ventilator. The
chart audit revealed that only one patient was treated using the clinically-indicated
CXR approach. Therefore, there needs to be an ongoing discussion regarding the use
of daily routine versus clinically-indicated CXRs for patients on ventilators as new
knowledge is developed. Chapter five presents recommendations for clinical
practice, policy development, research and education.
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CHAPTER V - DISCUSSION
INTRODUCTION
The purpose of this project was to determine if there were any differences in
patient outcomes with ICU patients on ventilators in the prevention of VAP between
those who received daily routine CXRs and those who received clinically-indicated
CXRs. The evidence-based practice question is: In the adult ICU patient on the
ventilator, is there a difference between daily routine CXRs and clinically-indicated
CXRs on patient outcomes of ICU length of stay, complications while on the
ventilator, ICU mortality, number of ventilator days, costs, and radiation exposure?
A retrospective chart audit of 60 patients on ventilators in the medical ICU was
conducted. Only one patient was managed with clinically-indicated CXRs, making it
impossible to compare the two groups. Chapter V presents recommendations and
implications for practice, policy development, research and education.
Recommendations for Practice
There is evidence supporting the use of clinically-indicated CXRs for patients
on ventilators in the ICU. The practice pattern in the medical ICU at the regional
healthcare system did not match the current literature findings. The author reported
findings of the retrospective chart audit to the medical ICU director who expressed
support for decreasing the number of CXRs that patients on ventilators receive.
Members of the intensivist staff were supportive in the reduction of the number of
CXRs patients on ventilators receive.
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Intensivist colleagues were supportive as well in the development of a practice
algorithm. The author has determined that there is a need for practice protocol
development for daily routine versus clinically-indicated CXRs. In addition there
needs to be an ongoing discussion among critical care providers regarding the need
for this change in practice.
Recommendation 1: There is currently enough evidence to change clinical practice.
Recommendation 2: Develop an ongoing dialogue among the professional staff
concerning evidence for CXR use.
Recommendation 3: Collect literature regarding indicators for the signs and
symptoms of CXRs for patients on ventilators.
Recommendation 4: Develop an algorithm.
Recommendation for Policy Development
Currently the medical ICU has no policy on daily routine versus clinicallyindicated CXRs for patients on the ventilator.
Recommendation 1: Develop a policy.
Recommendation for Research
It is possible to have quasi- experimental studies comparing patient outcomes
between these two methods of care.
Recommendation 1: Conduct more quasi-experimental studies comparing two
methods of care.
Recommendation 2: Test the algorithm developed by the practice group.

46

Recommendation for Education
Sensitizing the staff to the pros and cons of daily routine CXRs is important.
Nursing and radiology staff would need to be included in the process development for
identifying indicators for CXR use.
It is important to keep the conversation going between physicians, nurse practitioners,
nurses, radiologist, and other staff members so that a transition towards clinicallyindicated CXRs may be proposed.
Recommendation 1: Present findings of the evidenced-based practice project to the
staff.
Recommendation 2: Involve staff members in the development of clinical indicators
for the algorithm.
Summary
The author has identified that there needs to be ongoing discussion regarding the
use of daily routine versus clinically-indicated CXRs for patients on ventilators. The
main limitation for this quality improvement project included identifying only a small
number of patients in the authors practice site that receive clinically-indicated CXRs.
Therefore, the evidenced-based practice question is currently unable to be answered.
The analysis of the literature revealed that there is no advantage to daily routine CXRs
in the prevention of VAP.
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APPENDIX A
EVIDENCE TABLE
TABLE A.1 - EVIDENCE TABLE
Table A.1
Evidence Table
Level of
Evidence
Level II

Level I

Level I

Reference

Methods

Type of
Study/
System

(Clec “h et A
RCT
al., 2008) questionnair
completed.

Threat to Findings
Validity/
Reliability

Restrictive
use of CXRs
mv pt’s was
assoc. with b
diagnostic &
therapeutic
efficacies
without
impairing
outcomes.
(Ganapathy Medline & Quasi-RCT Quantitative Findings
The study
et al., 2012) Embase
review
were
did not
quantitative
unclear.
detect any
review.
harm
associated
with a restri
CXR
strategy
(Oba &
Systematic Meta
Literature Transition Daily
Zaza, 2010) review
analysis
Review
to
routine
on-demand CXRs
CXRs, but could be
identify
eliminated
sub-pop’s without
affecting
outcomes.

51

Rigorous
search and
multiple
experts
reviewing
data

The rate
of delayed
diagnoses in
restrictive
prescription
was 0.7%.
Mortality
was similar.

Conclusion

Level II

(Hejblum Random
Randomized Literature
et al., 2009) assignment Cluster- 2 Review
Crossover

Level III

(Hendrikse 2 part study Controlled
et al., 2007)
Study

Level II

(Krivopal Random
et al., 2003) selection

Random
Observation
Study

Level III

(Gratt
Random
et al., 2006) Selection

Prospective
Observation
Study

Level III

(Graat,
Random
et al., 2007) Selection

Prospective
nonrandomized,
controlled

Level V

(Graat,
Comparison Systematic
et al., 2005) of 2 groups Review
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32% CXR No
Reduction reduction in
w/clinically quality of
-indicated. pt care.
Journal
Most
Value is
provides
frequent
low and
strong
unexpected daily
evidence
abnormal- routine can b
for practice lities were: safely
progressive be
infiltrates, eliminated
and
confirmation
tube placem
Literature No
No
Review
Additional reduction
Benefits of in ICU stay,
Daily CXRs hospital stay
or reduced
mortality
Not all daily Daily
Daily
routine
routine
routine
CXRs
CXRs
CXRs
revealed
can be
rarely
unexpected eliminated showed
outcomes safely.
unexpected
outcomes.
Study
Diagnostic Daily
provided
&
routine
information therapeutic does
support the efficacy
not affect
research
Values were readmission
findings
not
rates, ICU
increased
and hospital
with
rate
daily CXRs
A questionwFound no Daily
was
difference routine
developed in mean
CXRs
to determine duration,
are safe, but
a difference hospital, or larger
between
ICU length o studies
2 groups.
stay b/t the need to be
two groups done

Level III

Level IV

Level IV

Level VII

Level VII

(Kager et al. Random
2010)
Selection

Nonrandomi Rigorous
Low
Study
controlled search and incidence concluded
study
multiple
of diagnostic efficacy of
experts
therapeutic routinely ob
reviewing efficacy of admission
CXRs is
the
routinely
evidence
CXRs
low
(Kroner
University Cohort
Clear
Recommend Daily
et al., 2008) study
study
objective
elimination routine
setting
identified an daily routine CXRs
researcher strategy
may not
affect
doesn’t
affect other practice of
diagnostic thoracic
imaging.
imaging in t
ICU
(Prat, 2009) Comparison Comparative Peer reviewe Found
Pt.
of 2 groups study
article,
reduction
outcomes
however no of testing
should not
distinct
i.e. daily
be affected g
objective
the push
routine
noted
CXRs
should
had no
be
adverse
towards ondemand
effect on
outcomes CXRs
(Fishman, J. Review of Expert
Unable to Found that Use of
Primack,
the
Opinion
rate the
CXRs
clinicallyS.,2005)
literature
evidence
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indicated
given the
to a change CXRs
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opinion
managemen indicated
Magill, et al Tiered
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Surveillance Key stake Executive
2013
approach
Opinion
should be holders
summary
applied to
objective, & proposed
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VAP
reliable.
new
a national
surveillance
approaches t approach to
VAP
surveillance
surveillance Ventilatoradult pt’s
Associated
Events

53

Level VII

(Siela,
2002)

Literature
Review

Level III

(Siegel,
2009)

Random
Selection

Expert
Opinion

Important
to
understand
anatomy&
physiology i
in correct
interpretatio
CXRs
Randomized Researcher On-demand Forgoing
study
identified CXRs
routine
no
yielded
CXRs
difference improved is more
in pt
pt outcomes beneficial to
outcomes without
pt’s &
adverse
decreasing
effects.
health care
costs
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Researcher
did provide
adequate
insight into
thoracic
imaging
interpretatio

CXRs
should be
read in a
systematic
method for
accuracy

APPENDIX B
RATING SYSTEM
Table B.1-HIERARCHY OF EVIDENCE

Level I:
Level II:

Level III:

Evidence from a systematic review or m
analysis of all relevant randomized clini
trials (RCT)
Evidence obtained from well-designed
(RCT)
Evidence obtained from well-designed
controlled trials without randomization

Level IV:
Level V:

Level VI:
Level VII:

Evidence from well-designed
case-control and cohort studies
Evidence from systematic reviews of
descriptive and qualitative studies
Evidence from single descriptive or
qualitative studies

Evidence from the opinion of
authorities and /or reports of expert
committees
Melnyk & Fineout-Overholt (2011).Evidenced-Based Practice in Nursing &
Healthcare. A Guide to Best Practice.
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